Literature DB >> 21349985

Immunomodulatory activities of surface-layer proteins obtained from epidemic and hypervirulent Clostridium difficile strains.

Manuela Bianco1, Giorgio Fedele1, Adriano Quattrini1, Patrizia Spigaglia1, Fabrizio Barbanti1, Paola Mastrantonio1, Clara M Ausiello1.   

Abstract

Surface-layer proteins (SLPs) have been detected in all Clostridium difficile strains and play a role in adhesion, although an involvement in the inflammatory process may also be supposed, as they cover the bacterial surface and are immunodominant antigens. The aim of this study was to evaluate the immunomodulatory properties of SLPs obtained from hypervirulent and epidemic (H/E) or non-H/E C. difficile strains, to try to determine whether they contribute to hypervirulence. SLPs were purified from H/E PCR ribotype 027 and 001 and non-H/E PCR ribotype 012 C. difficile strains, and the ability to modulate these properties was studied in human ex vivo models of monocytes and monocyte-derived dendritic cells (MDDCs). The results indicated that SLPs were able to induce immunomodulatory cytokines [interleukin (IL)-1β, IL-6 and IL-10] in monocytes. SLPs induced maturation of MDDCs, which acquired enhanced antigen-presenting activity, a crucial function of the mature stage. SLP-primed MDDCs expressed high levels of IL-10, an important regulatory cytokine. No significant differences were found in the activation induced in monocytes and MDDCs by SLP preparations from H/E and non-H/E strains. Overall, these findings show an important role for SLPs in modulation of the immune response to C. difficile. However, SLPs from H/E strains did not show a specific immunomodulatory pattern compared with SLPs from non-H/E strains, suggesting that SLPs are not involved in the increased severity of infection peculiar to H/E strains.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21349985     DOI: 10.1099/jmm.0.029694-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  18 in total

Review 1.  Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response.

Authors:  Gayatri Vedantam; Andrew Clark; Michele Chu; Rebecca McQuade; Michael Mallozzi; V K Viswanathan
Journal:  Gut Microbes       Date:  2012-03-01

Review 2.  Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen.

Authors:  Milena M Awad; Priscilla A Johanesen; Glen P Carter; Edward Rose; Dena Lyras
Journal:  Gut Microbes       Date:  2014

3.  Clostridium difficile recurrence is characterized by pro-inflammatory peripheral blood mononuclear cell (PBMC) phenotype.

Authors:  Mary B Yacyshyn; Tara N Reddy; Lauren R Plageman; Jiang Wu; Amy R Hollar; Bruce R Yacyshyn
Journal:  J Med Microbiol       Date:  2014-07-07       Impact factor: 2.472

Review 4.  The host immune response to Clostridium difficile infection.

Authors:  Katie Solomon
Journal:  Ther Adv Infect Dis       Date:  2013-02

Review 5.  The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection.

Authors:  Xingmin Sun; Simon A Hirota
Journal:  Mol Immunol       Date:  2014-09-18       Impact factor: 4.407

Review 6.  Immune responses to Clostridium difficile infection.

Authors:  Rajat Madan; William A Petri
Journal:  Trends Mol Med       Date:  2012-10-16       Impact factor: 11.951

7.  High Molecular Weight Typing with MALDI-TOF MS - A Novel Method for Rapid Typing of Clostridium difficile.

Authors:  Kristina Rizzardi; Thomas Åkerlund
Journal:  PLoS One       Date:  2015-04-29       Impact factor: 3.240

8.  Targeting surface-layer proteins with single-domain antibodies: a potential therapeutic approach against Clostridium difficile-associated disease.

Authors:  Hiba Kandalaft; Greg Hussack; Annie Aubry; Henk van Faassen; Yonghong Guan; Mehdi Arbabi-Ghahroudi; Roger MacKenzie; Susan M Logan; Jamshid Tanha
Journal:  Appl Microbiol Biotechnol       Date:  2015-05-05       Impact factor: 4.813

9.  RIPK3 Promotes Mefv Expression and Pyrin Inflammasome Activation via Modulation of mTOR Signaling.

Authors:  Deepika Sharma; Ankit Malik; Arjun Balakrishnan; R K Subbarao Malireddi; Thirumala-Devi Kanneganti
Journal:  J Immunol       Date:  2020-09-28       Impact factor: 5.426

10.  Clostridium difficile modulates host innate immunity via toxin-independent and dependent mechanism(s).

Authors:  Nazila V Jafari; Sarah A Kuehne; Clare E Bryant; Mamoun Elawad; Brendan W Wren; Nigel P Minton; Elaine Allan; Mona Bajaj-Elliott
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.